Breaking News

Financial Report: Sigma-Aldrich

February 7, 2013

Revenues up 7% in the quarter

4Q Revenues: $655 million (+7%)

4Q Earnings: $116 million (+7%)

FY Revenues: $2.6 billion (+5%)

FY Earnings: $460 million (+1%)

Comments: Growth in the quarter was driven by a 3% increase in Research and Sigma-Aldrich Fine Chemicals (SAFC) with sales growth of 2% and 5%, respectively. Acquisitions contributed 6% to sales growth.

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks